In liposarcoma, GYS1, the gene encoding glycogen synthase, predicted response to quisinostat, while analysis of global gene changes demonstrated that pathways involved in DNA replication, mitosis, and cell cycle were enriched for biomarkers of poor response to quisinostat, suggesting that highly proliferative cells were more resistant.44 Here, GYS1 is linked to liposarcoma.